Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome
- 22 January 2002
- Vol. 20 (9-10) , 1354-1364
- https://doi.org/10.1016/s0264-410x(01)00470-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Structures of Five Mutants of Toxic Shock Syndrome Toxin-1 with Reduced Biological Activity,Biochemistry, 1998
- Identification of antigenic sites on staphylococcal enterotoxin B and toxoidFEMS Immunology & Medical Microbiology, 1997
- A Mutation at Glycine Residue 31 of Toxic Shock Syndrome Toxin-1 Defines a Functional Site Critical for Major Histocompatibility Complex Class II Binding and Superantigenic ActivityThe Journal of Infectious Diseases, 1996
- Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolutionProtein Science, 1996
- Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.The Journal of Experimental Medicine, 1995
- Nucleotide Sequences and Biologic Properties of Toxic Shock Syndrome Toxin 1 from Ovine- and Bovine-Associated Staphylococcus aureusThe Journal of Infectious Diseases, 1992
- The Staphylococcal Enterotoxins and Their RelativesScience, 1990
- Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusingBiochemistry, 1986
- A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATESThe Lancet, 1981
- Immunogenicity of Formaldehyde-Inactivated Enterotoxins A and C1 of Staphylococcus aureusThe Journal of Infectious Diseases, 1975